The FDA is alerting healthcare professionals and patients about decreased survival associated with the use of pembrolizumab or atezolizumab as monotherapy therapy in clinical trials.
Posts in Oncology
ISMP leverages multidisciplinary expertise across hundreds of similar healthcare facilities to provide customized guidance on effective use of medication safety data.
Assess the safety of systems and practices associated with up to 11 categories of medications.
Proactively identify opportunities for reducing patient harm from chemotherapeutic agents.
Harness ISMP’s unparalleled experience and expertise to uncover root causes and hidden system failures and assist your organization in developing a comprehensive plan of action.
From one day high-alert safety check-ups to comprehensive enterprise risk assessments, ISMP helps uncover systemic areas that are vulnerable to medication error risk in your organization.